Trials / Conditions / Leukemia, Lymphoid

Leukemia, Lymphoid

9 registered clinical trials studyying Leukemia, Lymphoid — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia NCT06516679	Yonsei University	Phase 2
Not Yet Recruiting	Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT NCT06075238	Sichuan University	Phase 2
Unknown	Immune Reconstitution After Allo-HSCT and Blinatumomab NCT06075212	Sichuan University	—
Recruiting	Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL NCT06111625	Sichuan University	Phase 2
Completed	A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) NCT04849416	Eli Lilly and Company	Phase 2
Completed	Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG NCT02916979	Dartmouth-Hitchcock Medical Center	Phase 1
Completed	Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia NCT01116193	Institut de Cancérologie de la Loire	Phase 2
Terminated	A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With My NCT00569179	Indiana University School of Medicine	Phase 1
Completed	Analyses of Human Samples Collected in Clinical Trials NCT00339664	National Cancer Institute (NCI)	—